Search Results - "Salzman, Donna"
-
1
In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia
Published in PloS one (01-12-2016)“…Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose chemotherapy…”
Get full text
Journal Article -
2
Combinatorial suicide gene strategies for the safety of cell therapies
Published in Frontiers in immunology (14-09-2022)“…Gene-modified cellular therapies carry inherent risks of severe and potentially fatal adverse events, including the expansion of alloreactive cells or…”
Get full text
Journal Article -
3
Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients
Published in Supportive care in cancer (01-07-2012)“…Purpose This study seeks to investigate the use of extra-orally applied near-infrared phototherapy for the reduction of oral pain secondary to chemotherapy-…”
Get full text
Journal Article -
4
Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies
Published in EJHaem (01-06-2024)“…Relapse remains a major cause of treatment failure following allogeneic stem cell transplantation (allo‐SCT) for patients with acute myeloid leukemia (AML) and…”
Get full text
Journal Article -
5
Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients
Published in Clinical infectious diseases (01-05-2001)“…Invasive mold infections (IMIs) are an important cause of morbidity and mortality in patients who are undergoing bone marrow transplantation (BMT). To examine…”
Get full text
Journal Article -
6
Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia
Published in PloS one (15-02-2017)“…[This corrects the article DOI: 10.1371/journal.pone.0166891.]…”
Get full text
Journal Article -
7
Fatal sickle cell crisis after granulocyte colony-stimulating factor administration
Published in Blood (15-05-2001)Get full text
Journal Article -
8
Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies
Published in Blood (02-11-2023)“…Background: Allogeneic stem cell transplantation (allo-SCT) is potentially curative for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome…”
Get full text
Journal Article -
9
Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-03-2023)“…Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-hsct) can require intensive care unit (ICU) admission in the post-transplant…”
Get full text
Journal Article -
10
-
11
A Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Older Patients Using Fludarabine and Total Body Irradiation
Published in Blood (23-11-2021)“…Background: Older adults with acute lymphoblastic leukemia (ALL) have poor survival outcomes. Although allogeneic hemaptopoietic stem cell transplantation…”
Get full text
Journal Article -
12
Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53-Mutated Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
13
-
14
-
15
-
16
Risk Factors and Outcomes of ICU Admission Following Allogeneic Hematopoietic Stem Cell Transplantation
Published in Blood (23-11-2021)“…Background: Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-hsct) can develop complications such as life-threatening infections,…”
Get full text
Journal Article -
17
-
18
-
19
-
20
Standardized CD3+ Cell Dose for Allogeneic Peripheral Blood Stem Cell Transplant (PBSCT): An Interim Analysis
Published in Biology of blood and marrow transplantation (01-03-2016)Get full text
Journal Article